| Thomas S Park, RPH | |
|
23357 Pacific Coast Hwy, Malibu, CA 90265-4957 | |
| (310) 456-9059 | |
| (310) 456-6529 |
| Full Name | Thomas S Park |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 23357 Pacific Coast Hwy, Malibu, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194707562 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH46855 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas S Park, RPH 23357 Pacific Coast Hwy, Malibu, CA 90265-4957 Ph: (310) 456-9059 | Thomas S Park, RPH 23357 Pacific Coast Hwy, Malibu, CA 90265-4957 Ph: (310) 456-9059 |
News Archive
A paper published in the current issue of P&P by a group of researchers of the University of Bologna (headed by Professor Giovanni Fava) and a Harvard psychopharmacologist (professor Ross Baldessarini) has analyzed data that derive from randomized controlled trials concerned with the use of antidepressant drugs in children and adolescents.
The Diabetes Reversal Company has developed a pioneering programme based on weight loss, lifestyle change and one-to-one clinical support to reduce and reverse the effects of Type 2 diabetes, helping deliver the goals in the Government's newly published National Obesity Strategy.
When someone has a deadly disease or sustains a life-threatening injury, a transplant or graft of new tissue may be the best - or only - treatment option.
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
› Verified 9 days ago
Dr. Patricia Lee Mcnamee, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18325 Coastline Dr, Malibu, CA 90265 Phone: 310-459-5598 | |
Dr. Fred Joel Gould, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 29711 Baden Pl, Malibu, CA 90265 Phone: 310-457-2743 Fax: 310-457-2743 | |
Dr. Pantea Matian Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23805 Malibu Rd, Malibu, CA 90265 Phone: 310-456-9645 | |
Anjana Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 29211 Heathercliff Rd Ste 25, Malibu, CA 90265 Phone: 310-457-9707 | |
Dr. Shahram Soroudi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23357 Pacific Coast Hwy, Malibu, CA 90265 Phone: 310-456-9059 | |
Dr. Amanda Leigh O'hare, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23841 Malibu Rd, Malibu, CA 90265 Phone: 310-456-9645 |